Abstract
To find an ideal test technique for as low a dose of balsam of Peru (Myroxylon Pereirae) as possible, subjects testing positive to balsam of Peru are re-tested with a 25% concentration of balsam of Peru in petrolatum. Applications are with Finn Chambers® for 6 different application times, and directly by foils for 96 h (4 days (D)). The goals are to confirm which subjects are positive and which are not, and, using that information, to see if it is possible to distinguish between these 2 groups, tested concomitantly at much lower serial dose levels, in terms of perfusion or by visual assessments. 5 different serial doses are applied with strips for 3-96 h (4D) and with foils for 96 h (4D). The Finn Chamber® tests allow a distinction between visually positive and negative subjects supported by perfusion assessments. With the foils, a 24X lower serial dose level than with the 25% test substance is sufficient to distinguish between positive and negative subjects in terms of perfusion values. This approach requires readings up to 9 days. With this test, the visual approach yields only 3 of 10 positive subjects. This study demonstrates that a lower test dose is possible with perfusion assessments compared to visual ones.
Original language | English |
---|---|
Pages (from-to) | 326-329 |
Number of pages | 4 |
Journal | Contact Dermatitis |
Volume | 42 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2000 |
Other keywords
- Application time
- Balsam of Peru
- Bioengineering methods
- Dose level
- Laser Doppler perfusion imaging
- Myroxylon Pereirae
- Reading time
- Sensitivity
- Specificity
- Test procedure
- Test technique